chrisvoncsefalvay/vaers-outcomes huggingface dataset:
temporary delayed loss of taste; This is a spontaneous report from a contactable physician. A 67-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection) via an unspecified route of administration in left arm on 25Jan2021 at 19:00 (Lot number EL3247, Expiry date: Unknown) as 1st dose, single dose for COVID-19 immunisation at a hospital. Medical history included COVID-19 (in early November and did not lose sense of taste at that time) and allergic to Toradol. The patient's concomitant medications were not reported. The patient did not receive any other vaccination within 4 weeks and no medications were received within 2 weeks of vaccine administration. The patient was not tested for COVID after vaccine administration. On 03Feb2021, nine days after vaccine administration, the patient lost most of his sense of taste for two days. This was not a serious reaction just a peculiar one. There was no treatment received for the reported event. Outcome of the event was reported as recovered on an unknown date in Feb2021.  Follow-up (04Jun2021): This follow-up is being submitted to notify that follow-up attempts completed. No further information expected. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021205778 same drug and AE, different patient
inadvertently administered a 3-year-old patient who was supposed to receiving the first dose in the primary series, with a dose of the booster vaccine; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team, Program ID:   A 3-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 1 (maroon cap; booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "inadvertently administered a 3-year old patient who was supposed to bereceiving the first dose in the primary series, with a dose of the booster vaccine".  Additional information: The reporter (nurse), called regarding the COVID-19 booster; stated that they inadvertently administered a 3-year-old patient who was supposed to be receiving the first dose in the primary series, with a dose of the booster vaccine. The nurse wanted to know if the patient would still need a second dose or if the patient is considered fully vaccinated.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
I recieved the H1N1 shot at my 6.5 OBGYN appointment that morning. I became extremely tired for evening. I was so tired I could hardly walk or move my arms. This lasted two more days. That Saturday Jan. 9th I had a braxton hicks contraction while walking into a grocery store. The following two weeks my abdomen hurt when in bed at night and I experienced one more braxton hicks. After two weeks I started bleeding and an ultrasound confirmed I had miscarried at 6.5 to 7 weeks. Two days later I had a D&C. I firmly believe the vaccine caused my miscarriage. At that 6.5 week appointment my OBGYN Dr. could see the heart beat if she tilted the ultrasound monitor just right. She confirmed my baby had a heart beat and was in the uterus where it needed to be. It died right after that shot.
Initial report was received from a healthcare provider on 05 October 2011. A 90-year-old female patient had received an Intramuscular (IM) injection of FLUZONE High-Dose; lot number UH452AA (site of administration not reported) on 27 September 2011. On the same day of the injection, the patient complained of nausea, vomiting for six hours, fever (102) for forty eight hours and blisters on upper lip which have dried out. No further information was available at the time of the report. The patient outcome was reported as recovered/resolved. Documents held by sender: none.
With in a few minutes of receiving Flu Mist intranasally, patient developed red non-raised spots to the side of her face, she started to state that her "head felt dizzy", she became pale, stated she couldn't hear anything, and had a blank stare almost passing out.  She was still at the clinic, so we mentioned this to the assistant, laid her down in a room, gave her a sucker and some water; Another physician came and assessed her.  She began to regain her color and feel better after about 15 minutes.
01/17/22 presents to ED for "Heart Racing" "SOB, lightheadedness, fatigue". PMHx of "VTE-PE on Warfarin, CKD, and HTN"
erythema and pruritis to left arm around immediate site of the vaccine, monitored for 30min and appeared to improve - erythema almost completely resolved, no rash presented anywhere else and pt had no respiratory symptoms and felt fine. Recommended Benadryl 25-50mg if itching persisted and advised follow-up for additional care if symptoms worsened. Called to follow up the next day and check on the pt, had initially improved but then worsened and had redness and hives to both arms, then to back, neck and chest. pt took Claritin (about an hour or more after benadryl) and symptoms improved over several hours - they did not seek additional medical attention and today pt is back to baseline.  She never had any wheezing, coughing, swelling or difficulty swallowing - no respiratory symptoms at all. Given the rash worsened to chest and back and symptoms took >4hrs to resolve, recommended she NOT return for her second dose due to increased risk of a more severe allergic reaction. Notified PCP and recommended f/u with PCP for any additional questions or concerns.
Patient was given shot and 10 mins later came to the counseling window with parent. The patient had hives on her backside of trunk and face. Parent stated daughter has had similar outbreaks recently due to unknown cause but they are going to a prescriber to try to figure out the cause. There were no complaints of difficulty breathing. Diphenhydramine 25mg was administered to patient and they left.
DTaP given on 06/02/2003, left upper arm red, swollen, warm to touch 6"x4" redness on 06/04/2003.
inconsolabel crying for 2 hrs; immun given 230PM; fussy 2 hrs p/; crying began 630PM-inconsolable screaming not high pitched sounded; as in pain;
Injection site reaction with softball size swelling and redness. Not painful and no difficulty in breathing. No other symptoms.
Case number PHEH2015US019413, is an initial spontaneous report received from a pharmacist on 30 Sep 2015. This report refers to an 11 years old male patient. Medical history and concomitant medications were not reported. The patient was inadvertently vaccinated with FLUCELVAX (batch number: unknown) at a dose of 0.5 ml intramuscularly 29 Sep 2015. No adverse event was reported. No further information was provided.
Severe flu-like symptoms: Body aches, fever, uncontrollable shivering, fatigue and weakness.  Onset: `3.5 hours post injection with sudden onset continuing into the night. Symptoms have improved briefly but still continue 9.5 hrs post-vaccination.  Treatment: 600mg Ibuprofen IO q/6hr
headache; sore throat; body aches; dizziness that got really bad with the fever; chills; felt like she had the flu; fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PAIN (body aches), DIZZINESS (dizziness that got really bad with the fever), CHILLS (chills) and INFLUENZA LIKE ILLNESS (felt like she had the flu) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PAIN (body aches), DIZZINESS (dizziness that got really bad with the fever), CHILLS (chills), INFLUENZA LIKE ILLNESS (felt like she had the flu) and PYREXIA (fever). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), PAIN (body aches), DIZZINESS (dizziness that got really bad with the fever), CHILLS (chills), INFLUENZA LIKE ILLNESS (felt like she had the flu), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Seen in our office 4/1/2006 with c/o left parotid area of swelling Dx Parotitis.
Started with feeling really cold, unable to warm up. Checked my temperature and it went to 102.7 stayed above 101 for 14 hours. Severe leg and lower back/kidney pain for 8 hours. Chills on and off all day. Severe dry mouth no matter how much I drank.  Headache
Fine rash on face/neck- reported as "occurs within 2 weeks of injection" reported 1/3/02-fine rash remains, hydrocortisone 1 % cream BID x 2 ayd and Benadryl 25 mg 1 p.o @ H. S. X 3 nights
day 29 mid afternoon, I felt an explosion in the right ear. This caused a destabilization of the sound in that ear, which was heard louder on the right than on the left. On the 30th, around 9am, I began to feel that I couldn't close my right eye well, and around 11am, the right side of my mouth became paralyzed. it was like a paralysis on the right side of the face. I have no strength on the right side to blow my nose, the right eye does not close properly, and the mouth on the right side does not move the same as the left.
pt presented with acute respiratory failure and confusion; DKA; tested positive for COVID; experienced AFib; worsening respiratory failure; comfort measures instituted; pt's condition worsened and he passed away in the hospital
1. Had a breakthrough COVID July 31, stayed in quarantine ten days--until August 10. Symptoms at that time were mild: one day of fever, occasional mild headache, trouble sleeping, decrease in appetite, and loss of the sense of taste and smell. The latter has persisted on and off since that time. Sometimes I taste or smell things, sometimes I don't taste or smell some things I am around.  2. Received my booster (third shot) Nov 12 2021. About three days later, I noticed a metallic taste in my mouth. It was particularly strong about 5-7 days out from the booster--very unpleasant for eating. Now it is not as offensive, but has tapered off to being present (still all the time), but with some foods it is milder. Right now, anything that is acidic, such as grapes, citrus, tomatoes, and such it comes on very strong while I eat. Milk and oatmeal do not elicit the strong sensation, but it is still there.
pATIENT SAID THAT HE GOT A SMALL  RASH ON BOTH ARMS STARTING THE DAY AFTER HIS SHOT. IT DID NOT APPEAR TO BE VACCINE RELATED TO ME BUT FELT THAT I SHOULD REPORT IT. SEEMED MORE LIKE CONTACT DERMATITIS. PATIENT SAID THAT HE IS OUTSIDE A LOT BUT THAT IS WAS NOT POISON IVY BUT IT LOOKED SIMILIAR TO ME. THE RASH HAD IMPROVED AND WAS ALMOST GONE WHEN HE CAME IN. HE SAID HE DIDN'T KNOW IF IT WAS RELATED BUT THOUGHT HE SHOULD SHARE IT.
Possible blood clot; had severe hives; Greater then 35 days without getting second dose; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose). At the time of the report, THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: possible blood clot (abnormal) possible blood clot.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No relevant concomitant medications were reported. No treatment information was reported.  Very limited information regarding this events has been provided at this time.  Event of thrombosis was automatically upgraded as a Serious event as per IME list. However, based on information available and as per medical criteria was classified as Non-serious. Further information is not expected as there is no consent for follow up.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Event of thrombosis was automatically upgraded as a Serious event as per IME list. However, based on information available and as per medical criteria was classified as Non-serious. Further information is not expected as there is no consent for follow up.
Headache, Fever, chills, muscle ache Narrative:  employee states: he experienced low grade fever, chills, muscle aches, and a headache. The symptoms continued the next day but improved with Tylenol and Motrin. He had no side effects with the first dose.
Currently left hand is swollen. The top of the middle finger is swollen. The back of my hand is swollen and this has happen with all of my Moderna 1st Dose, Moderna 2nd Dose and Moderna Booster.
headache, low grade fever 99.9, body aches, chills began today on 2/1/21 sore arm began on 1/31/21
Seen in ER on 4/1/08 due to severe local reaction. Area on arm where shot given bright red and puffy, no fever or SOB. I saw this girl on 4/2 and arm was still puffy and redness about 3 1/2' diameter. On 4/4, mom said on phone swelling and redness almost to elbow. Not very sore-using aloe vera. Also suggested hydrocortisone OTC cram. 4/7/08 Talked to mom redness and swelling resolved. Lump and some bruising at injection site remains.
patient received the diluent component of HIBERIX without the powder component; patient received the diluent component of HIBERIX without the powder component; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 9-month-old female patient who received Hib (Hiberix) (batch number FT775, expiry date 26th June 2022) for prophylaxis.   On 21st June 2021, the patient received Hiberix. On 21st June 2021, unknown after receiving Hiberix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The medical assistant reported that, pediatric female patient received the diluent component of HIBERIX without the powder component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
pt recv vax 24JUN97 & 1JUL97 t106 ear & persisted to 12JUL97;UTI found 4JUL97 d/t E coli but fever persisted;pt fretful; had sz;EEG & MRI negative;
Patient was scheduled for and received a COVID-19 Monovalent booster vaccine during the first week of September 2022. During this same week, the CDC published guidance recommending the Bivalent booster vaccine for 12 years and up. The patient was informed about the difference and the option of getting a Bivalent booster in 2 months.
Patient  developed difficulty breathing after vaccine was administered and was taken to the ED.  She was administered Solu-Medrol and Benadryl IV with good results.  She was discharged home at 1906.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 19-JAN-2017, the patient was vaccinated with a dose of PROQUAD (dose and route unknown, lot # M034692, expiration date: 24-JAN-2018) which was improperly stored, for prophylaxis. The vaccine was stored in 6.3 Fahrenheit degree for 11 hours. There was no previous temperature excursion. The call was not because of a data logger. No adverse effects were reported. Additional information has been requested.
HOT FLASHES, SWEATS, (I AM BEYOND MENOPAUSE) REDNESS AT INJECTION SITE THAT INCREASED. SEVERE MUSCLE SORENESS ALL OVER. SEVERE INTESTINAL DISTRESS AND NAUSEA, VOMITING.
Fever greater than 101 degrees, chills, swelling of arm with redness elbow to shoulder, body aches.
Patient was getting tingly, lightheaded, pale, and eyes rolling back after receiving her first dose of the Pfizer Covid vaccine.  We gave her some glucose tablets and she seemed to get better afterwards.  I did a pulse oximeter on her her and her pulse and oxygen was normal.  I offered mother if she wanted me to call 911 and she said no.  I counseled mother and the girl to monitor how she is feeling and to seek 911 or urgent care if she gets worst throughout the day.  The girl left the store feeling okay.
CLIENT STATED SHE BECAME DIZZY AND FELT VERY FAINT- NPTED CLENT TO SAETING ON FLOOR-INITIAL B/P-94/49-P-58 P.O2-98-17;25- 113/72-P. 72-02 SAT-99--17:30-115/85-78  CLIENT WAS GIVEM WATER AMD GIVEN TIME RECOVERY- CLIEMT DID ADMITT SHE HAD DRUNK 3 CUPS OF COFFEE BEFORE RECEIVING VACCINE--ALSO SHE GETS VERY ANXIOUS WHEN RECEING SHOTS
Pt reported for what they thought was 2nd shingles shot (Shingrix). Pt had documentation from nearby clinic stating date of first shot and were within time frame for 2nd shot. Pt had no recollection of getting 2nd shot and no documentation to provide to show that they had received 2nd shot. Pharmacist administered vaccination and only upon looking up the pt in the Immunization Registry saw that they had already received their 2nd shot. Pharmacist reached out to pt-pt had no memory of receiving 2nd shot and pt is fine status post vaccination. Pharmacist also touched base with clinic where they did have record of pt checking in on day of 2nd shot. In hindsight, pharmacist should have verified vaccine hx in the Immunization Registry prior to giving the shot regardless of pt documentation.
This spontaneous report as received from a pharmacist refers to a 71 years old female patient. The patient was vaccinated with a dose of 0.65 ml ZOSTAVAX (lot # not reported) on 20-AUG-2012. If this was the first time the patient had gotten ZOSTAVAX could not be confirmed. Concomitant mediations included: INFLUENZA (unspecified) (manufacturer unknown) vaccinated in the opposite arm on 20-AUG-2012. It was reported that on 21-AUG-2012, "the following day", the patient had developed redness, swelling and warmth at the injection site. The patient came to the pharmacy on 23-AUG-2012 and said that the injection site reaction had gotten larger and there were still redness, warmth and swelling. No rash had been reported. And there was no injection site reaction in the arm vaccinated with the flu vaccine. The patient sought for unspecified medical attention. Treatment given was reported as none. Lab diagnostics studies performed were reported as none. The outcome was reported as not recovered. Additional information is not expected.
This was (spikevax) Moderna.  Patient did not elaborate but mentioned allergic reaction including "head spinning"
Symptom onset 10/02/2021. Symptoms: Congestion, fever, cough, shortness of. breath, abdominal discomfort, headache, fatigue, myalgia, chills, eye pressure, change in taste, constipation. Admitted to Hospital on 10/03/2021. Has received breathing treatments.
Flu symptoms for over a week so far. Headache, body aches, fatigue, nausea and heart palpitations. Pain in chest in heart area. Symptoms have not resolved yet.
No additional AEs; expired dose of PROQUAD administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concomitant medications, concurrent conditions and drug allergies were not reported.  On 10-MAR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot number: T030945, expiration date: 09-MAR-2022 (expired product administered), dose 0,5 ml, subcutaneously (SQ) (formulation and injection site was not provided) for prophylaxis. No additional adverse events were reported.
A consumer report has been received. The report concerns a 9 month old, Male consumer, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient's mother reported that her baby given FLUMIST QUADRIVALENT instead of the flu shot to 10 month old which started on 25-Sep-2013. The outcome of the event GIVEN FLUMIST QUADRIVALENT INSTEAD OF THE FLU SHOT TO 10 MONTH OLD is unknown. The report was considered to be non-serious.
This case was reported by a other health professional via sales rep and described the occurrence of injection site rash in a 84-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included autoimmune disorder. Concomitant products included PREVENAR. On 18th June 2018, the patient received the 1st dose of SHINGRIX. On 19th June 2018, 1 days after receiving SHINGRIX, the patient experienced injection site rash. The patient was treated with prednisone and BENADRYL. On an unknown date, the outcome of the injection site rash was recovering/resolving. It was unknown if the reporter considered the injection site rash to be related to SHINGRIX. Additional information was received as follows: This case was reported by Physician Assistant, Certified (PA-C). The age at vaccination was not reported. On 16th June 2018, the patient received PREVENAR 13. The patient received PREVENAR and SHINGRIX on different arms. The patient broke out with a bad rash on both arms at the site of injection extending down to her hands. The patient received the 5 day prescription for Prednisone. The patient was seen by the provider on 21st June 2018, the patient was not better at that time. On 28th June 2018, the patient was improving but still had the rash, a prescription for BENADRYL was called in. The provider stated that the patient would not be completing the SHINGRIX series as she did not know which vaccine caused the reaction.
After receiving the vaccine I experienced extreme fatigue. In August after seeing my physician we did a B12 test that came out very low. I had constant numbness and tingling in my lower leg and feet. I noticed occasional numbness in my forearm and hands, and also occasional very slight tremors in my hands. I have continued dizziness. On August 3rd I tested for Covid after being vaccinated and it was positive. On September 9th I did another Covid test and it was negative. I received the Covid tests from a drive thru testing site.